Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro

Islet amyloid deposition in human type 2 diabetes results in β-cell loss. These amyloid deposits contain the unique amyloidogenic peptide human islet amyloid polypeptide (hIAPP), which is also a known substrate of the protease insulin-degrading enzyme (IDE). Whereas IDE inhibition has recently been...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Endocrinology
Huvudupphovsmän: Hogan, Meghan F., Meier, Daniel T., Zraika, Sakeneh, Templin, Andrew T., Mellati, Mahnaz, Hull, Rebecca L., Leissring, Malcolm A., Kahn, Steven E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Endocrine Society 2016
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007890/
https://ncbi.nlm.nih.gov/pubmed/27404391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2016-1410
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk